In the context of metabolic regulation and obesity, both endogenous and synthetic GPCR ligands have gained increasing attention for their ability to modulate signaling pathways involved in appetite control, energy expenditure, and hormone sensitivity (56, 57). The gene discussed is GPBAR1; the disease is obesity disorder.